ASC Durango (Colo.) recently underwent its first AAAHC survey and achieved accreditation. One of the areas the ASC was praised by surveyors for was its quality assessment and performance improvement ...

There are many risk factors for developing postoperative nausea and vomiting (PONV), but a simplified risk score can help with assessing those risk factors, said Jawad N. Saleh, PharmD, BSPharm, BCCCP ...

NEW ORLEANS -- There was no benefit to giving patients supplemental oxygen during surgery to reduce postoperative nausea and vomiting (PONV), according to a post hoc analysis of a randomized trial.

The latest Consensus Guidelines for the Management of PONV (CGM-PONV) recommend an assessment of a patient's baseline risk for PONV using a validated risk score based on independent predictors. The ...

Heron Therapeutics (HRTX) announced the inclusion of APONVIE injectable emulsion in the newly released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting: Executive ...

The anticonvulsant medication gabapentin—already a useful part of strategies to control pain after surgery—also effectively reduces the common complication of postoperative nausea and vomiting (PONV), ...

APONVIE, an aprepitant product, highlighted as the only FDA-approved IV formulation Neurokinin-1 (“NK-1”) antagonist indicated for the prevention of PONV in adults, with a long half-life and quicker ...

DURHAM, N.C. – A Duke University Medical Center anesthesiologist who analyzed studies of postoperative nausea and vomiting (PONV) believes that better communication between physicians and patients ...

MIAMI, Sept. 28, 2022 /PRNewswire/ -- Brand Institute is proud to announce its work with Heron Therapeutics in developing the brand name APONVIE™, which was approved by the FDA September 16, 2022.

Objective: To review the literature on the prevention of postoperative nausea and vomiting (PONV) in adults. Data Sources: Literature retrieval was accessed through MEDLINE (1966-December 2006) using ...